CSIMarket
 


Aclaris Therapeutics Inc   (ACRS)
Other Ticker:  
 


Aclaris Therapeutics Inc 's ROA from the fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Aclaris Therapeutics Inc 's ROA in the fourth quarter of 2023?
Aclaris Therapeutics Inc recorded a cumulative net loss of $-88 million during 12 months ending in the fourth quarter of 2023, resulting in a negative return on assets (ROA) of -39.75%.

However, within the Healthcare sector 326 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Dec 31 2023 quarter, so far to 2741, from total ROA ranking in the third quarter of 2023 at 4068.

What is ROA?


Return On Assets (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Total Assets Change -22.02 % -17.54 % -14.07 % 2.16 % 1.85 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -88 -115 -105 -96 -87
Return On Assets (TTM) -39.75 % -48.43 % -42.39 % -37.29 % -33.82 %
ACRS's Total Ranking # 2741 # 4068 # 4191 # 4224 # 4708
Total Assets (TTM) in million 200 221 239 231 256
Seq. Total Assets Change -9.6 % -7.57 % 3.17 % -9.55 % -4.4 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 121
Sector # 327
Overall # 2732

Return On Assets Statistics
High Average Low
-31.44 %
-55.55 %
-97.34 %
(Mar 31 2022)   (Mar 31 2020)



  News about Aclaris Therapeutics Inc

Aclaris Therapeutics: Charting a Path to Financial Reinvention and Leadership Reinforcement



Aclaris Therapeutics, a prominent player in the healthcare sector, has recently announced significant leadership changes and a strategic business review. The decision comes after a period of financial underperformance, with the company's year-to-date stock performance showing a decline of 12%. Additionally, Aclaris Therapeutics reported a net loss of $115 million for the twelve months leading up to the third quarter of 2023, resulting in a negative return on assets (ROA) of -48.43%. This article delves into the implications of these developments and the potential impact on the company's overall market standing within the healthcare sector.
Transition in Leadership:
One of the significant changes within Aclaris Therapeutics is the stepping down of Douglas Manion, M.D., as the Chief Executive Officer, President, and Member of the Board of Directors. Dr. Manion had been at the helm of the company during a period of financial struggles. This leadership transition presents an opportunity for the company to explore fresh perspectives and operational strategies. Aclaris Therapeutics will be on the lookout for a new CEO who can steer the company towards stability and profitability.




Financial Statements
Aclaris Therapeutics Inc 's Assets $ 200 million ACRS's Balance sheet
Aclaris Therapeutics Inc 's Income $ -1 million Quarterly ACRS's Income Statement
ACRS's Income by Division See ACRS's Income by Division



Annual Return On Assets (Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
(Dec 31 2020)
FY 2020
(Dec 31 2019)
FY 2019
Y / Y Total Assets Change -22.02 % 1.85 % 254.9 % -27.99 % -64.33 %
Total Assets in million 200 256 251 71 98
Y / Y Net Income Change - - - - -
Net Income in million -88 -87 -91 -51 -161
Return On Assets -44.35 % -33.97 % -36.17 % -72.07 % -164.15 %




More Return On Assets Ratios
ACRS's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ACRS's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Roa for ACRS's Competitors
Roa for Aclaris Therapeutics Inc 's Suppliers
Return On Assets for ACRS's Customers

You may also want to know
ACRS's Roi ACRS's Inventory Turnover Ratio ACRS's Growth Rates ACRS's Dividend Comparisons
ACRS's Profitability Ratios ACRS's Asset Turnover Ratio ACRS's Dividend Growth
ACRS's Roe ACRS's Valuation Ratios ACRS's Financial Strength Ratios ACRS's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2023, within Healthcare Sector ROA


Date modified: 2024-02-27T17:35:43+00:00


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com